Plans Say Prior Authorization Is Necessary For MAT, AMA Disagrees

By Chelsea Cirruzzo / September 13, 2019 at 6:13 PM
Plans say prior authorization for medication-assisted treatment (MAT) for individuals with substance use disorders helps the treatment be used safely and effectively, but providers are worried that prior authorization is a barrier to treatment in the middle of an opioid crisis. America’s Health Insurance Plans (AHIP) and BlueCross BlueShield defended prior authorization to the House Committee on Small Business on Wednesday (Sept. 11) in a written statement submitted for the hearing on prior authorization and other forms of utilization management...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.